147 related articles for article (PubMed ID: 3181291)
21. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
22. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
Pranzatelli MR; Snodgrass SR
Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Lorens SA; Hata N; Cabrera T; Hamilton ME
NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
[No Abstract] [Full Text] [Related]
24. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
25. Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.
Stewart RM; Campbell A; Sperk G; Baldessarini RJ
Psychopharmacology (Berl); 1979 Feb; 60(3):281-9. PubMed ID: 108706
[No Abstract] [Full Text] [Related]
26. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
Butler PD; Pranzatelli MR; Barkai AI
Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
[TBL] [Abstract][Full Text] [Related]
27. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.
Quattrone A; Schettini G; Annunziato L; Di Renzo G
Eur J Pharmacol; 1981 Nov; 76(1):9-13. PubMed ID: 7318925
[TBL] [Abstract][Full Text] [Related]
29. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
[TBL] [Abstract][Full Text] [Related]
30. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
Black RS; Robinson RG
Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
[TBL] [Abstract][Full Text] [Related]
31. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
32. Effect of hypothalamic injections of 5,7-dihydroxytryptamine on elicitation of mouse-killing in rats.
Vergnes M; Kempf E
Behav Brain Res; 1982 Aug; 5(4):387-97. PubMed ID: 6889881
[TBL] [Abstract][Full Text] [Related]
33. [Compensation in behavioral disorders in rats receiving 5,7-DHT neonatally and by transplantation of embryonic raphe nucleus tissue].
Semenova TP; Gromov EA; Grishchenko NI; Nesterova IV; Bragin AG; Vinogradova OS; Kulikov AV; Smirnova GN; Tret'iak TM
Zh Vyssh Nerv Deiat Im I P Pavlova; 1990; 40(1):156-64. PubMed ID: 2162591
[TBL] [Abstract][Full Text] [Related]
34. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
35. Effects of hypothalamic serotonin depletion on lordosis behavior and gonadal hormone receptors.
Luine VN; Thornton JE; Frankfurt M; MacLusky NJ
Brain Res; 1987 Nov; 426(1):47-54. PubMed ID: 3690318
[TBL] [Abstract][Full Text] [Related]
36. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
[No Abstract] [Full Text] [Related]
37. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.
Lucot JB; Seiden LS
Psychopharmacology (Berl); 1982; 77(2):114-6. PubMed ID: 6812128
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
Breese GR; Vogel RA; Mueller RA
J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
[TBL] [Abstract][Full Text] [Related]
39. Increased behavioural response to intrathecal serotonin after lesion of serotonergic pathways with 5,7-dihydroxytryptamine seems not to be due to depletion of serotonin.
Eide PK; Hole K
Acta Physiol Scand; 1988 Oct; 134(2):291-4. PubMed ID: 2976239
[TBL] [Abstract][Full Text] [Related]
40. [The effects of constituents of an antitussive and expectorant preparation on physical dependence on and antitussive activity of dihydrocodeine].
Yoshii T; Masukawa Y; Fukagawa Y; Suzuki T; Misawa M; Yanaura S
Arukoru Kenkyuto Yakubutsu Ison; 1990 Oct; 25(5):419-28. PubMed ID: 1980411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
